Development and characterization of anti-EGFR protein-drug conjugates for tumor therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Bielefeld, Universität Bielefeld, Dissertation, 2022
- Schlagwort
-
Signaltransduktion
Krebs
- Ereignis
-
Veröffentlichung
- (wo)
-
Bielefeld
- (wer)
-
Universitätsbibliothek Bielefeld
- (wann)
-
2022
- Urheber
- URN
-
urn:nbn:de:0070-pub-29642721
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:47 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Karsten, Lennard
- Universitätsbibliothek Bielefeld
Entstanden
- 2022
Ähnliche Objekte (12)
Peptide-drug conjugates for advanced targeted cancer therapy
Antibody–drug conjugates as an emerging therapy in oncodermatology
Novel cryptophycin analogues and conjugates for tumor targeted therapy
Development of novel peptide-drug-conjugates for targeted breast cancer therapy
Oligosaccharides based antibacterial drug conjugates
Improved Drug Delivery of next-generation Antibody-Drug Conjugates by utilizing tumor-associated proteases
EGFR binding Fc domain-drug conjugates: stable and highly potent cytotoxic molecules mediate selective cell killing
α-Amanitin-based Small Format-Drug Conjugates for Prostate Cancer Therapy: Enabling Anti-Tumor Activity by Tuning Pharmacokinetic Properties
Chemoselective synthesis of functional drug conjugates
Development of peptide-drug conjugates targeting mitochondria
Drug therapy
Molecular analyses of resistance and sensitivity mechanisms to anti-EGFR directed tumor therapy
Peptide-drug conjugates for advanced targeted cancer therapy
Antibody–drug conjugates as an emerging therapy in oncodermatology
Novel cryptophycin analogues and conjugates for tumor targeted therapy
Development of novel peptide-drug-conjugates for targeted breast cancer therapy
Oligosaccharides based antibacterial drug conjugates
Improved Drug Delivery of next-generation Antibody-Drug Conjugates by utilizing tumor-associated proteases
EGFR binding Fc domain-drug conjugates: stable and highly potent cytotoxic molecules mediate selective cell killing
α-Amanitin-based Small Format-Drug Conjugates for Prostate Cancer Therapy: Enabling Anti-Tumor Activity by Tuning Pharmacokinetic Properties
Chemoselective synthesis of functional drug conjugates
Development of peptide-drug conjugates targeting mitochondria
Drug therapy
Molecular analyses of resistance and sensitivity mechanisms to anti-EGFR directed tumor therapy
Peptide-drug conjugates for advanced targeted cancer therapy
Antibody–drug conjugates as an emerging therapy in oncodermatology
Novel cryptophycin analogues and conjugates for tumor targeted therapy
Development of novel peptide-drug-conjugates for targeted breast cancer therapy
Oligosaccharides based antibacterial drug conjugates
Improved Drug Delivery of next-generation Antibody-Drug Conjugates by utilizing tumor-associated proteases
EGFR binding Fc domain-drug conjugates: stable and highly potent cytotoxic molecules mediate selective cell killing
α-Amanitin-based Small Format-Drug Conjugates for Prostate Cancer Therapy: Enabling Anti-Tumor Activity by Tuning Pharmacokinetic Properties
Chemoselective synthesis of functional drug conjugates
Development of peptide-drug conjugates targeting mitochondria
Drug therapy